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In the mid-1950b. clored digital dilation of the aot!~s valve 
WE first cmnloved in tix trentment of calciiic aurtic steno- 
sis. The ope;&e tonality rate was IO% to 20% (I,ZJ and at 
follow-uo. 50% to 70% of survI.~ors had nn imoroved New 
York H&t Association functionai class or weie judged to 
have a good clinical result (1.3). However. by 1958, one of 
the pioneers of this technique, Charles Bailey, MD. had 
abandoned the procedure in favor ofopen repair 14). primar- 
ily because of high morbidtty and mortality. BY 1963. pros- 
thetic sonic valve replacement (5) became the treatment of 
choice. Pcrcuttineou~ balloon aortic valvuloplasly emerged 
as a treatment option for patients with symptomatic, severe 
c&tic awtic stenosis (6). fiy the late 1980s. it was adwtcd 
by some as the treatment of choice in “sick” patients over 
the age of 80 yeem !?!. 
The cuxcni study. is iitis issue of titc Journal. Bernard 
and colleagues (8) provide important data comparing Ihe 
etlicacy of bs!lwn aortic valvuloplasty *ida that of aortic 
valve replacement. In dieiy?roup of69 pettents over the age 
of 75 years with aortic stenosis. the choice between the two 
procedwes was made by the patient. This resulted in two 
nonrandomized but simi!ar groups. with 46 patients (Group 
1) undergoing balloon aortic valvuloplasty and 23 (Group 2) 
undergomg aortic valve replacement with a biopmsthesis. 
The twc groups were well matched for age and baseline 
mean aortic valve gradient. Aortic valve area in Group I WBE 
0.43 cm’ hut was not reported for Group 2. After the 
interventional procedure, both groups were followed up for 
approximately 2 years. The in-ho&al mortality rate was 
6.5% in Group I. but during the follow-UP period. 52% of 
Group I patients died, 3SC underwent aoriif valve replace- 
ment for recurrent symptoms and only 6.5% were alive and 
had not been operated on. In contrast, the Group 2 in. 
hospital mortality rate was 8.7%. the post-hospital mortality 
rate was 13% and all survivors were doing well. 
Importance of thia study. All patients were acceptable 
candidates for aortic valve replacement at the bcginni;lg of 
the study. There WBL no bias toward performing balloon 
sonic valvuloplasty on “sicker” patients who bad been 
refused operation because of perceived excessive surgical 
risk. In prior studies (9) of balloon aortic valvuloplasty, 
roueblv 30% of oatients had been formallv denied surgical 
v&e feplaeeme~t by the consulting surge&t. Thereforeythis 
is the first series comparing the results of balloon aortic 
valvuloplasty with surgical valve replacement in comparable 
patients. 
Limitations of the study. As noted by the investigators 
(8). the study is retrospective and nonrandomized. Although 
alve areas were not reported for the surgical patients. tile 
groups were matched clinically and hemodynamically. 
Comparison with previous studies. Two large multicenter 
series of balloon aonic valvuloplasty have recently been 
reported. The National Heart, Lung, and Blood Institute 
Registry (IO) incbtded 674 patients. Aortic valve area was 
0.5 cm2 before and 0.8 cm’ after valvuloplarty. In-hospital 
mortality was 10.2%. and at the l-month followup 54% of 
the total group had improvement by at least one New York 
Heart Association functional class or remained in stage 1 
(IO). 
The Maoslield Scien:iftc Aortic Valvuloplasty Registry 
(9.11-15) comprised 492 patients. The in-hospital mortality 
rate xi 7.:X (i I) and tine morbidity rate was 20.5% (12). 
The morbiditv consisted of vascular injury in II%, a ttzn- 
sient ischemic episode or stroke in 2.2%. ventricular perfo- 
ration in 1.8% and massive aortic regurgitation in 1% (with 
resultant emergency aottic valve replacement in four of five 
patients). Balloon aortic valvuloplasty increased aortic valve 
area from 0.5 to 0.82 cm*. very similar to the increase 
reported in the National Heart, Lung, and Blood Institute 
Registry (IO) and greater than the increase of 9.47 to 0.63 
cm* in the current study (8). The I-year survival rate was 
64% in the Mansfield Registry (9). but only 36% of the total 
cohort remained in clinically improved condition without 
valve replacement (14). All of these results are similar to 
those of previous smaller studies (16). Bernard et al. (8) 
obwved that several studies (17.18) have shown better early 
hemodynamic results, but even those lbuvc a I-year survival 
rate of only 65% in the absence oi subsequent aortic valve 
replacement. However, in other studies (19.20) the survival 
rate without subsequent surgical aortic valve replacement 
was only 30% at a follow-up interval of I5 to I7 months. A 
Mayo Clinic natural history study (21) of candidates for 
balloon aottic valvuloplasty who were followed up without 
intervention revealed an actuarial I- and 2.year survival rate 
of 57% and 37%. respectively. Thus, balloon sonic valvulo- 
plasty confers a modest increase in survival at I year but 
“o”e at 2 years. 
Surgical mortality for aortic vatve replacement in elderly 
patients has ranged from 3% to 2R% in recent series (22-25) 
and tends to cluster around 6% to 9% for aortic valve 
operative monality raw was 13% for patients over age 70 
years who had an eiection frxtion of C40%. 
Cliieal implications. Because sonic v&e replacemenr 
provides superior results to those of balloon aortic VBIVUIO- 
planly. only a few indications for the latter exist. tlalloon 
aortic valvuloplasty may be indicaled in I b patients who have 
comorbid ronditiow [ha: confer a Me expectancy of <I 
year. and 2) some moribund patients requiring emergency 
intervention. The latter patients will have a poor prognosis 
with either intervention. 
In contras, IO the excellent long-term rcsulis of closed 
surgical mitral commissurotomy G3.291 and !he excellent 
intermediate-term results of percutaneous mitral balloon 
valvuloplasty l30.31). the results of balloon aortic VPIYUIO- 
plasty have the same poor rewlts that were associated wilh 
closed surgical aortic valvutomy. 
In 19%. Bailey (4) wrote, “Today it seems to me rhat it IS 
wrong to continue these closed techniques. We do nor 
accomplish much opening of lhe stenotic valve by any closed 
method. It is not surprising that many of our surviving 
patients are beginning to show evidencr of recurrence of the 
stenosis and will require further (more adequate) interven- 
tivn in the fwure.” BIS ccmmrnts about clsscd .xgica! 
dilation of the stenotic aortic valve in 19% can be aoolied to 
balloon aortic valvuloplaaty today. 
